Chief Executive Officer
CurrentSpectraNomix is a biotechnology R&D company which extends beyond genomics and proteomics into the emerging fields of metabolomics & metabonomics to discover novel biomarkers related to unmet medical need. SpectraNomix has established proprietary technologies for molecular target discovery through identification of unique disease molecular signatures based on the intrinsic fluorescence properties of disease-related molecules. Learn more at www.spectranomix.com